The American Diabetes Association and American Association of Clinical Endocrinologists have not issued specific guidance endorsing compounded GLP-1 receptor agonists as equivalent alternatives to FDA-approved products
Helpfully, recent policy changes regarding cost may make having a variety of options to readily choose from more possible from an affordability perspective
Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, and Boyd AE, 3rd
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide act on appetite and satiety the same way
Once you stop taking them, the impact on your gut microbiome may diminish. Even when we went away for a beach weekend and I forgot to bring them, I noticed I didnt get super hungry
Mayo Clinics data has women on tirzepatide plus hormone therapy losing 19.2% of body weight against 14% on tirzepatide alone